Trials / Completed
CompletedNCT02598115
Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older
Impact of the Implementation of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 622 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older. This is a cluster-randomized study with a stepped-wedge design. Clusters correspond to participating centers. A randomly selected center is crossed-over into the intervention every fifteen days after the start of inclusions.
Detailed description
The secondary objectives are to evaluate: A. The potential and observed clinical impact of the implementation of collaborative pharmaceutical care. B. The acceptance rate of pharmaceutical interventions during collaborative pharmaceutical care. C. Avoidable costs related to the consumption of care generated by the occurrence of serious adverse drug reactions. D. The satisfaction of health professionals concerning the transfer of information on the patient's drug therapy carried out as part of collaborative pharmaceutical care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Collaborative Pharmaceutical Care | The pharmacist performs collaborative pharmaceutical care in the ward: reconciliation of drug treatments and revision of drug prescriptions indicated on the admission drug prescription. He/she emits pharmaceutical interventions recorded on the standardized support provided by the French Society of Clinical Pharmacy. The pharmaceutical interventions are discussed during a collaborative interview. |
Timeline
- Start date
- 2016-09-19
- Primary completion
- 2016-12-25
- Completion
- 2016-12-25
- First posted
- 2015-11-05
- Last updated
- 2020-02-28
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02598115. Inclusion in this directory is not an endorsement.